Teladoc Investor Day Presentation Deck

Long-term operating plan/financial algorithm Revenue Adj. EBITDA(1) margin Teladoc Guidance HEALTH 20% - 30% annual organic growth (1) See adjusted EBITDA reconciliation immediately following this presentation. + 200 - 300 bps expansion per year Comment • Continued growth in member base Expanded cross selling/upselling • International expansion beyond core markets Expanded product offerings to all facets of virtual primary care and specialty care ● ● ● ● Balanced growth across subscription, visits and M&A Pricing leverage ● Continued economies of scale in technology, sales and G&A • Continued marketing efficiencies Teladoc Health, Inc Investor Day 2020 136

View entire presentation